BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV – Get Free Report) saw a significant drop in short interest in July. As of July 31st, there was short interest totalling 3,600 shares, a drop of 25.0% from the July 15th total of 4,800 shares. Based on an average daily volume of 154,400 shares, the days-to-cover ratio is currently 0.0 […]
Jerusalem - BiondVax Pharmaceuticals Ltd. , a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products primarily for the treatment of. -Today at 09:42 am- MarketScreener
BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV – Get Free Report) saw a large decline in short interest in the month of July. As of July 31st, there was short interest totalling 3,600 shares, a decline of 25.0% from the July 15th total of 4,800 shares. Based on an average daily trading volume, of 154,400 shares, the short-interest […]
StockNews.com began coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV – Free Report) in a research note released on Monday. The firm issued a hold rating on the stock. BiondVax Pharmaceuticals Stock Up 1.5 % BiondVax Pharmaceuticals stock opened at $1.32 on Monday. The business’s 50-day simple moving average is $1.41 and its 200 day simple […]
BiondVax Pharma (BVXV) Reports Q2, Provides Business Update streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.